Danish enzyme producer Novozymes presents its third-quarter fiscal report on Tuesday, revealing an upgrade to its guidance for the remaining year.
The company now eyes organic sales growth of 5-6 percent as well as an earnings margin before interest and taxes of around 27 percent. The previous expectation was for organic sales growth to reach 4-6 percent and the earnings margin to hit 26 percent.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.Start a free company trial today
Your trial for EnergyWatch has now started
With your free trial you get:
Full access to all locked articles on EnergyWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.